Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907, USA.
Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia.
Int J Pharm. 2019 Apr 20;561:102-113. doi: 10.1016/j.ijpharm.2019.02.018. Epub 2019 Feb 21.
Combinational antibiotic formulations have emerged as an important strategy to combat antibiotic resistance. The main objective of this study was to examine effects of individual components on the antimicrobial activity, physico-chemical properties, aerosolization and dissolution of powder aerosol formulations when three synergistic drugs were co-spray dried. A ternary dry powder formulation consisting of meropenem (75.5 %w/w), colistin (15.1 %w/w) and rifampicin (9.4 %w/w) at the selected ratio was produced by spray drying. The ternary formulation was characterized for in-vitro antibacterial activity, physico-chemical properties, surface composition, aerosol performance and dissolution. All of the formulations demonstrated excellent aerosolization behavior achieving a fine particle fraction of >70%, which was substantially higher than those for the Meropenem-SD and Colistin-Meropenem formulations. The results indicated that rifampicin controlled the surface morphology of the ternary and binary combination formulations resulting in the formation of highly corrugated particles. Advanced characterization of surface composition by XPS supported the hypothesis that rifampicin was enriched on the surface of the combination powder formulations. All spray-dried formulations were amorphous and absorbed substantial amount of water at the elevated humidity. Storage at the elevated humidity caused a substantial decline in aerosolization performance for the Meropenem-SD and Colistin-Meropenem, which was attributed to increased inter-particulate capillary forces or particle fusion. In contrast, the ternary combination and binary Meropenem-Rifampicin formulations showed no change in aerosol performance at the elevated storage humidity conditions; attributable to the enriched hydrophobicity of rifampicin on the particle surface that acted as a barrier against moisture condensation and particle fusion. Interestingly, in the ternary formulation rifampicin enrichment on the surface did not interfere with the dissolution of other two components (i.e. meropenem and colistin). Our study provides an insight on the impact of each component on the performance of co-spray dried combinational formulations.
联合抗生素制剂已成为对抗抗生素耐药性的重要策略。本研究的主要目的是研究三种协同药物共喷雾干燥时,各成分对抗菌活性、物理化学性质、气溶胶化和溶解的影响。采用喷雾干燥法制备由美罗培南(75.5%w/w)、黏菌素(15.1%w/w)和利福平(9.4%w/w)按选定比例组成的三元干粉制剂。对三元配方进行了体外抗菌活性、物理化学性质、表面成分、气溶胶性能和溶解的表征。所有配方均表现出良好的气溶胶化行为,达到>70%的细颗粒分数,明显高于美罗培南-SD 和黏菌素-美罗培南制剂。结果表明,利福平控制了三元和二元组合制剂的表面形态,形成了高度波纹状的颗粒。XPS 对表面成分的高级表征支持了利福平在组合粉末制剂表面富集的假说。所有喷雾干燥的制剂都是无定形的,在高湿度下吸收大量水分。在高湿度下储存会导致美罗培南-SD 和黏菌素-美罗培南的气溶胶化性能大幅下降,这归因于颗粒间毛细管力或颗粒融合的增加。相比之下,三元组合和二元美罗培南-利福平制剂在高储存湿度条件下气溶胶性能没有变化;这归因于利福平在颗粒表面的富集疏水性,起到了阻止水分凝结和颗粒融合的作用。有趣的是,在三元配方中,利福平在表面的富集并不干扰其他两种成分(即美罗培南和黏菌素)的溶解。本研究深入了解了每个成分对共喷雾干燥组合制剂性能的影响。